RHOEN-KLINIK.UNSP.ADR 1/2 (RHKU) - Total Liabilities
Based on the latest financial reports, RHOEN-KLINIK.UNSP.ADR 1/2 (RHKU) has total liabilities worth €523.09 Million EUR (≈ $611.55 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore RHKU cash flow conversion to assess how effectively this company generates cash.
RHOEN-KLINIK.UNSP.ADR 1/2 - Total Liabilities Trend (2021–2024)
This chart illustrates how RHOEN-KLINIK.UNSP.ADR 1/2's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of RHOEN-KLINIK.UNSP.ADR 1/2 to evaluate the company's liquid asset resilience ratio.
RHOEN-KLINIK.UNSP.ADR 1/2 Competitors by Total Liabilities
The table below lists competitors of RHOEN-KLINIK.UNSP.ADR 1/2 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sam Engineering Equipment
KLSE:9822
|
Malaysia | RM565.93 Million |
|
Oscotec Inc
KQ:039200
|
Korea | ₩43.01 Billion |
|
Cardinal Infrastructure Group Inc. Class A Common Stock
NASDAQ:CDNL
|
USA | $255.05 Million |
|
CytomX Therapeutics Inc
NASDAQ:CTMX
|
USA | $39.41 Million |
|
Pantoro Limited
F:RKN
|
Germany | €183.49 Million |
|
Anhui Sierte Fertilizer Industry Ltd Co
SHE:002538
|
China | CN¥1.02 Billion |
|
Anyang Iron & Steel Inc
SHG:600569
|
China | CN¥43.65 Billion |
|
Ningbo Solartron Technology Co Ltd
SHG:688299
|
China | CN¥1.28 Billion |
Liability Composition Analysis (2021–2024)
This chart breaks down RHOEN-KLINIK.UNSP.ADR 1/2's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of RHOEN-KLINIK.UNSP.ADR 1/2.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.40 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how RHOEN-KLINIK.UNSP.ADR 1/2's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for RHOEN-KLINIK.UNSP.ADR 1/2 (2021–2024)
The table below shows the annual total liabilities of RHOEN-KLINIK.UNSP.ADR 1/2 from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €530.51 Million ≈ $620.22 Million |
+8.20% |
| 2023-12-31 | €490.30 Million ≈ $573.21 Million |
+8.11% |
| 2022-12-31 | €453.51 Million ≈ $530.20 Million |
+2.88% |
| 2021-12-31 | €440.82 Million ≈ $515.36 Million |
-- |
About RHOEN-KLINIK.UNSP.ADR 1/2
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, provides in-patient, semi-patient, and outpatient healthcare services in Germany. The company also operates acute hospitals, medical care centers, and rehabilitation hospitals. RHÖN-KLINIKUM Aktiengesellschaft was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.